Previous close | 12,026.00 |
Open | 12,070.00 |
Bid | 11,980.00 x 0 |
Ask | 11,984.00 x 0 |
Day's range | 11,882.00 - 12,144.00 |
52-week range | 9,461.00 - 12,186.00 |
Volume | |
Avg. volume | 2,944,566 |
Market cap | 185.842B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 37.00 |
EPS (TTM) | 3.24 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 2.28 (1.90%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | 122.46 |
As you might know, AstraZeneca PLC ( LON:AZN ) just kicked off its latest quarterly results with some very strong...
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
Fusion (FUSN) is expected to provide updates regarding the developmental program of its lead candidate, FPI-2265, for prostate cancer in the first-quarter earnings release.